Precision BioSciences (DTIL) Misses Q4 EPS by 222c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts DTIL Hot Sheet
Join SI Premium – FREE
Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of ($2.22). Revenue for the quarter came in at $640 thousand.
For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASM International posts Q3 net income of €308.1m, raises 2027 revenue target
- MercadoLibre (MELI) call put ratio 1.3 calls to 1 put as share price up 1.2%
- Boeing (BA) call put ratio 1.1 calls to 1 put as share price down
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
